The effect of short-chain fatty acids on human monocyte-derived dendritic cells
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The gut microbiota is essential for human health and plays an important role in the pathogenesis of several diseases. Short-chain fatty acids (SCFA), such as acetate, butyrate and propionate, are end-products of microbial fermentation of macronutrients that distribute systemically via the blood. The aim of this study was to investigate the transcriptional response of immature and LPS-matured human monocyte-derived DC to SCFA. Our data revealed distinct effects exerted by each individual SCFA on gene expression in human monocyte-derived DC, especially in the mature ones. Acetate only exerted negligible effects, while both butyrate and propionate strongly modulated gene expression in both immature and mature human monocyte-derived DC. An Ingenuity pathway analysis based on the differentially expressed genes suggested that propionate and butyrate modulate leukocyte trafficking, as SCFA strongly reduced the release of several pro-inflammatory chemokines including CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11. Additionally, butyrate and propionate inhibited the expression of lipopolysaccharide (LPS)-induced cytokines such as IL-6 and IL-12p40 showing a strong anti-inflammatory effect. This work illustrates that bacterial metabolites far from the site of their production can differentially modulate the inflammatory response and generally provides new insights into host-microbiome interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Short-chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, produced by commensal bacteria during starch fermentation, strongly modulate gene expression in human monocyte-derived DCs, thus reducing the secretion of multiple proinflammatory chemokines and inhibiting the expression of LPS-induced cytokines with enhanced activity against inflammation (110).”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
(2023) · doi:10.1126/science · Cited by 6,063
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Topping, D. L., & Clifton, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1031 · Cited by 3,091
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
“SCFA, in particular propionate and butyrate, have also been shown to inhibit the expression of lipopolysaccharide (LPS)-induced cytokines, IL-6 and IL12p40 in human mature dendritic cells.(84) Of the few clinical studies that have used SCFA therapeutically in inflammatory disease in a controlled trial setting,”
BackgroundThe Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Short chain fatty acids in human gut and metabolic health
Blaak, E. E., Canfora, E. E., Theis, S., Frost, G., Groen, A. K., Mithieux, G., Nauta, A., Scott, K., Stahl, B., van Harsselaar, J., et al. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0057 · Cited by 1,103
“Whereas incubation of human monocyte-derived DCs with acetate did not elicit significant changes in the transcriptome, butyrate and propionate reduced the release of several pro-inflammatory chemokines and inhibited the expression of LPS-induced cytokines (Nastasi et al. , 2015).”
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Sun, M., Wu, W., Liu, Z., & Cong, Y. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1242-9 · Cited by 1,047
“Butyrate and propionate inhibit activation of BMDC via suppressing the LPS-induced expression of co-stimulatory molecule CD40 and secretion of IL-6 and IL-12p40 [33].”
BackgroundMicrobial Regulation of Host Physiology by Short-chain Fatty Acids
van der Hee, B., & Wells, J. M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.001 · Cited by 980
Nogal, A., Valdes, A. M., & Menni, C. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1897212 · Cited by 917
“In human mature dendritic cells, butyrate and propionate appear to reduce the release of pro-inflammatory chemokines, such as CXCL11, CXCL10, CXCL9, CCL5, CCL4, and CCL3, just as inhibiting the expression of LPS-induced cytokines, including IL-6 and IL12p40.”
BackgroundWestern Diet and the Immune System: An Inflammatory Connection
Christ, A., Lauterbach, M., & Latz, E. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.020 · Cited by 907
The role of short-chain fatty acids in immunity, inflammation and metabolism
Yao, Y., Cai, X., Fei, W., Ye, Y., Zhao, M., & Zheng, C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1854675 · Cited by 756
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
O'Riordan, K. J., Collins, M. K., Moloney, G. M., Knox, E. G., Aburto, M. R., Fülling, C., Morley, S. J., Clarke, G., Schellekens, H., & Cryan, J. F. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111572 · Cited by 713
Yang, W., & Cong, Y. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00661-4 · Cited by 679
Gut-Microbiota-Derived Metabolites Maintain Gut and Systemic Immune Homeostasis
Wang, J., Zhu, N., Su, X., Gao, Y., & Yang, R. (2023) · Cells · doi:10.3390/cells12050793 · Cited by 588
Gut microbiota-derived short-chain fatty acids and their role in human health and disease
Mukhopadhya, I., & Louis, P. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01183-w · Cited by 501
“Butyrate and propionate have been found to have a critical role in the differentiation, maturation and function of these cells towards a predominant tolerogenic phenotype 85 .”
Cockburn, D. W., & Koropatkin, N. M. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.06.021 · Cited by 539
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)
Ratajczak, W., Rył, A., Mizerski, A., Walczakiewicz, K., Sipak, O., & Laszczyńska, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2648 · Cited by 514
Hays, K. E., Pfaffinger, J. M., & Ryznar, R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393270 · Cited by 453
“123 Butyrate is known to contribute to host defense by inducing the anti-microbial protein cathelicidin LL-37 in the gut.”
BackgroundMicrobiota-gut-brain axis: Modulator of host metabolism and appetite
van de Wouw, M., Schellekens, H., Dinan, T. G., & Cryan, J. F. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.240481 · Cited by 461
“These include the regulation of the chemotaxis and inflammation of neutrophils (235–237) and the suppression of inflammatory cytokine production of monocytes and macrophages (238, 239), as well as T regulatory, T helper 1, and T helper 17 cell differentiation and subsequent cytokine production (240–243).”
BackgroundDietary fiber and SCFAs in the regulation of mucosal immunity
Tan, J. K., Macia, L., & Mackay, C. R. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.007 · Cited by 421
Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
Wen, L., & Duffy, A. (2017) · The Journal of Nutrition · doi:10.3945/jn.116.240754 · Cited by 412
“These SCFAs can strongly modulate gene expression of human monocytes and reduce proinflammatory cytokine and chemokine production by monocytes (32, 33).”
BackgroundPathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
The gut-bone axis: How bacterial metabolites bridge the distance
Zaiss, M. M., Jones, R. M., Schett, G., & Pacifici, R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128521 · Cited by 403
“Tregs suppress conventional T cells through a variety of mechanisms, including the production and secretion of the immunosuppressive cytokines IL-10 and TGF-β (92, 93).”
BackgroundInfluentialGonçalves, P., Araújo, J. R., & Di Santo, J. P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 393
Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
Akhtar, M., Chen, Y., Ma, Z., Zhang, X., Shi, D., Khan, J. A., & Liu, H. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2021.11.005 · Cited by 363
Microbiome-Driven Allergic Lung Inflammation Is Ameliorated by Short-Chain Fatty Acids
Cait, A., Hughes, M. R., Antignano, F., Cait, J., Dimitriu, P. A., Maas, K. R., Reynolds, L. A., Hacker, L., Mohr, J., Finlay, B. B., et al. (2018) · Mucosal Immunology · doi:10.1038/mi.2017.75 · Cited by 394
The Immunomodulatory Functions of Butyrate
Siddiqui, M. T., & Cresci, G. A. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s300989 · Cited by 381
Immune regulation by microbiome metabolites
Kim, C. H. (2018) · Immunology · doi:10.1111/imm.12930 · Cited by 375
Marizzoni, M., Cattaneo, A., Mirabelli, P., Festari, C., Lopizzo, N., Nicolosi, V., Mombelli, E., Mazzelli, M., Luongo, D., Naviglio, D., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200306 · Cited by 333
“Butyrate ameliorated the pro-inflammatory response of immune cells to antigen stimulus as LPS by expanding the Treg cell populations [57] and by reducing the expression of pro-inflammatory cytokines (i.e., IL-6) in human mature dendritic cells [58].”
Wenzel, T. J., Gates, E. J., Ranger, A. L., & Klegeris, A. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103493 · Cited by 320
Uribe-Herranz, M., Rafail, S., Beghi, S., Gil-de-Gómez, L., Verginadis, I., Bittinger, K., Pustylnikov, S., Pierini, S., Perales-Linares, R., Blair, I. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124332 · Cited by 316
“Butyrate and propionate treatment of human DCs significantly reduced LPS-induced Il6 mRNA and Il12 gene expression and enhanced leukocyte trafficking, and SCFAs strongly reduced the release of several proinflammatory chemokines (46).”
BackgroundMethodInfluentialIkeda, T., Nishida, A., Yamano, M., & Kimura, I. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108273 · Cited by 271
Implications of the Westernized Diet in the Onset and Progression of IBD
Rizzello, F., Spisni, E., Giovanardi, E., Imbesi, V., Salice, M., Alvisi, P., Valerii, M. C., & Gionchetti, P. (2019) · Nutrients · doi:10.3390/nu11051033 · Cited by 250
“SCFAs play important multifactorial roles in energy homeostasis, host immune function [25,27] and general gut physiology [25,28] (Table 1).”
BackgroundKaisar, M. M. M., Pelgrom, L. R., van der Ham, A. J., Yazdanbakhsh, M., & Everts, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01429 · Cited by 238
“Importantly, to date, there has only been a single study assessing the effects of SCFAs on human DCs, in which particularly butyrate was found to suppress LPS-induced maturation (14).”
BackgroundResultInfluentialSchistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses
Costain, A. H., MacDonald, A. S., & Smits, H. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03042 · Cited by 222
“polygyrus bakeri infection, and down-regulate the pro-inflammatory effector functions of intestinal macrophages (140, 149, 160, 161).”
BackgroundGut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging
Biragyn, A., & Ferrucci, L. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30095-0 · Cited by 202
Hanus, M., Parada-Venegas, D., Landskron, G., Wielandt, A. M., Hurtado, C., Alvarez, K., Hermoso, M. A., López-Köstner, F., & De la Fuente, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612826 · Cited by 199
Review article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 180
Wu, L., Zeng, T., Zinellu, A., Rubino, S., Kelvin, D. J., & Carru, C. (2019) · mSystems · doi:10.1128/msystems.00325-19 · Cited by 191
Metabolic programming in dendritic cells tailors immune responses and homeostasis
Møller, S. H., Wang, L., & Ho, P.-C. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00753-1 · Cited by 169
Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm
Jain, A., & Pasare, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602000 · Cited by 172
Commensal bacteria contribute to insulin resistance in aging by activating innate B1a cells
Bodogai, M., O’Connell, J., Kim, K., Kim, Y., Moritoh, K., Chen, C., Gusev, F., Vaughan, K., Shulzhenko, N., Mattison, J. A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat4271 · Cited by 182
“As an inhibitor of Toll-like receptor 4 (TLR4) signaling (9) and histone deacetylases (10), a decrease in butyrate in the intestine also allows microbes and microbial products to efficiently activate the production of proinflammatory cytokines and chemokines in myeloid cells (11).”
BackgroundTerkawi, M. A., Matsumae, G., Shimizu, T., Takahashi, D., Kadoya, K., & Iwasaki, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031786 · Cited by 193
“Butyrate and propionate are the most important SCFAs that are known to facilitate the differentiation of CD4 T cell into regulatory T cells (Tregs) and macrophages into an anti-inflammatory phenotype resulting in an anabolic state needed for bone formation [157,161].”
BackgroundThe "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis
Freedman, S. N., Shahi, S. K., & Mangalam, A. K. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0588-x · Cited by 168
Sanford, J. A., Zhang, L.-J., Williams, M. R., Gangoiti, J. A., Huang, C.-M., & Gallo, R. L. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah4609 · Cited by 166
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, C. M., Geisler, C., Andersen, M. H., Ødum, N., & Woetmann, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-15099-w · Cited by 157
Self-citationA mosquito salivary protein promotes flavivirus transmission by activation of autophagy
Sun, P., Nie, K., Zhu, Y., Liu, Y., Wu, P., Liu, Z., Du, S., Fan, H., Chen, C.-H., Zhang, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14115-z · Cited by 161
Yuan, X., Wang, L., Bhat, O. M., Lohner, H., & Li, P. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.007 · Cited by 168
“may inhibit the expression of lipopolysaccharide (LPS)-induced production of inflammatory cytokines including neutrophil chemoattractant [55,74,75].”
BackgroundInfectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
Iacob, S. A., & Iacob, D. G. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01676 · Cited by 175
Role of Dendritic Cells in Inflammation and Loss of Tolerance in the Elderly
Agrawal, A., Agrawal, S., & Gupta, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00896 · Cited by 153
“SCFAs synthesized by gut microbiota can act on DCs to prevent their activation and enhance their capacity to induce T regulatory cells to maintain tolerance in the gut (81).”
BackgroundImpact of prebiotics on immune response: from the bench to the clinic
Pujari, R., & Banerjee, G. (2021) · Immunology & Cell Biology · doi:10.1111/imcb.12409 · Cited by 143
“Under in vitro conditions, butyrate and propionate have also been shown to downregulate the LPS-induced costimulatory molecules CD83, CD80, CD40 and chemokine receptors and skew polarization of the na€ıve T-cell toward IL-10-producing type 1 Tregs that contribute toward resilience.(53) In addition, propionate and buty…”
BackgroundGut Microbiome as Target for Innovative Strategies Against Food Allergy
Canani, R. B., Paparo, L., Nocerino, R., Scala, C. D., Gatta, G. D., Maddalena, Y., Buono, A., Bruno, C., Voto, L., & Ercolini, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00191 · Cited by 149
Microbial Metabolites Determine Host Health and the Status of Some Diseases
Sittipo, P., Shim, J.-W., & Lee, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215296 · Cited by 136
Mishra, S. P., Karunakar, P., Taraphder, S., & Yadav, H. (2020) · Biomedicines · doi:10.3390/biomedicines8060154 · Cited by 136
Cardiac metabolism in HFpEF: from fuel to signalling
Capone, F., Sotomayor-Flores, C., Bode, D., Wang, R., Rodolico, D., Strocchi, S., & Schiattarella, G. G. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac166 · Cited by 154
Microbial Metabolites and Gut Immunology
Takeuchi, T., Nakanishi, Y., & Ohno, H. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-102035 · Cited by 148
Romick-Rosendale, L. E., Haslam, D. B., Lane, A., Denson, L., Lake, K., Wilkey, A., Watanabe, M., Bauer, S., Litts, B., Luebbering, N., et al. (2018) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2018.07.030 · Cited by 130
Clavel, T., Gomes‐Neto, J. C., Lagkouvardos, I., & Ramer‐Tait, A. E. (2017) · Immunological Reviews · doi:10.1111/imr.12578 · Cited by 123
Kibbie, J. J., Dillon, S. M., Thompson, T. A., Purba, C. M., McCarter, M. D., & Wilson, C. C. (2021) · Immunobiology · doi:10.1016/j.imbio.2021.152126 · Cited by 109
Verma, A., Bhagchandani, T., Rai, A., Nikita, N., Sardarni, U. K., Bhavesh, N. S., Gulati, S., Malik, R., & Tandon, R. (2024) · ACS Omega · doi:10.1021/acsomega.3c05846 · Cited by 136
“168 Inflammatory illness may be brought on by Treg cell dysfunction or absence.”
BackgroundSanford, J. A., O’Neill, A. M., Zouboulis, C. C., & Gallo, R. L. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800893 · Cited by 125
Short chain fatty acids, a possible treatment option for autoimmune diseases
Golpour, F., Abbasi-Alaei, M., Babaei, F., Mirzababaei, M., Parvardeh, S., Mohammadi, G., & Nassiri‐Asl, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114763 · Cited by 133
Ciarlo, E., Heinonen, T., Herderschee, J., Fenwick, C., Mombelli, M., Le Roy, D., & Roger, T. (2016) · Scientific Reports · doi:10.1038/srep37944 · Cited by 113
Gut microbial metabolites SCFAs and chronic kidney disease
Meng, H., Wei, W., Zhang, Y., Xiang, Z., Peng, D., Kasimumali, A., & Rong, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04974-6 · Cited by 128
“SCFAs can also act on immune cells, regulating leukocyte transport by reducing the expression of chemokines in dendritic cells derived from human monocytes to inhibit macrophage and dendritic cell recruitment [102].”
BackgroundGut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Shui, L., Yang, X., Li, J., Yi, C., Sun, Q., & Zhu, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02989 · Cited by 115
“Short-chain fatty acids (SCFAs), such as acetate, butyrate, and propionate, produced by commensal bacteria during starch fermentation, strongly modulate gene expression in human monocyte-derived DCs, thus reducing the secretion of multiple proinflammatory chemokines and inhibiting the expression of LPS-induced cytokin…”
BackgroundSong, Y., Malmuthuge, N., Steele, M. A., & Guan, L. L. (2017) · FEMS Microbiology Ecology · doi:10.1093/femsec/fix179 · Cited by 115
The Food-gut Human Axis: The Effects of Diet on Gut Microbiota and Metabolome
Angelis, M. D., Garruti, G., Minervini, F., Bonfrate, L., Portincasa, P., & Gobbetti, M. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170428103848 · Cited by 118
Xiao, L., van de Worp, W. R. P. H., Stassen, R., van Maastrigt, C., Kettelarij, N., Stahl, B., Blijenberg, B., Overbeek, S. A., Folkerts, G., Garssen, J., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201847971 · Cited by 119
ZEB 1‐regulated inflammatory phenotype in breast cancer cells
Katsura, A., Tamura, Y., Hokari, S., Harada, M., Morikawa, M., Sakurai, T., Takahashi, K., Mizutani, A., Nishida, J., Yokoyama, Y., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12098 · Cited by 124
“Notably, the amounts of proteins secreted by MDA-231-D cells were comparable to the levels secreted by inflammatory cells, suggesting that IL-6 and IL-8 were produced at functional levels (Nastasi et al., 2015; Pazmandi et al., 2012).”
BackgroundLiu, W., Luo, X., Tang, J., Mo, Q., Zhong, H., Zhang, H., & Feng, F. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02431-w · Cited by 121
Microbiota–Host Transgenomic Metabolism, Bioactive Molecules from the Inside: Miniperspective
Turroni, S., Brigidi, P., Cavalli, A., & Candela, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00244 · Cited by 108
Self-citationThe Gut‒Breast Axis: Programming Health for Life
Rodríguez, J. M., Fernández, L., & Verhasselt, V. (2021) · Nutrients · doi:10.3390/nu13020606 · Cited by 116
Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice
Xiao, L., Land, B. V., Engen, P. A., Naqib, A. D., Green, S. J., Nato, A., Leusink-Muis, T., Garssen, J., Keshavarzian, A., Stahl, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22052-y · Cited by 117
New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases
Hong, W., Yang, B., He, Q., Wang, J., & Weng, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841687 · Cited by 115
Emerging role of gut microbiota in autoimmune diseases
Wang, X., Yuan, W., Yang, C., Wang, Z., Zhang, J., Xu, D., Sun, X., & Sun, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1365554 · Cited by 130
“Furthermore, these acids enhance and sustain the integrity of the intestinal epithelial barrier function in lupus-prone animals (57, 133, 134).”
BackgroundGut microbiota as a key regulator of intestinal mucosal immunity
Wang, J., He, M., Yang, M., & Ai, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122612 · Cited by 112
The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids
Sam, Q. H., Ling, H., Yew, W. S., Tan, Z., Ravikumar, S., Chang, M. W., & Chai, L. Y. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126453 · Cited by 108
“While the anti-inflammatory propensity of SCFA has been described by others [13,30] we further showed associated down-regulation of TRAF3 and IRF3 expression by butyric acid on C.”
BackgroundMicrobiota—myeloid cell crosstalk beyond the gut
Gorjifard, S., & Goldszmid, R. S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0516-222r · Cited by 96
“Whereas SCFAs did not affect the generation of BM monocytes and neutrophils, they influenced DC hematopoiesis by increasing the number of macrophage and DC precursors and CDPs in the BM [72] (Fig.”
InfluentialCheng, L., Jin, H., Qiang, Y., Wu, S., Yan, C., Han, M., Xiao, T., Yan, N., An, H., Zhou, X., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.018 · Cited by 98
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V., & Wargo, J. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.007 · Cited by 98
Dürholz, K., Hofmann, J., Iljazovic, A., Häger, J., Lucas, S., Sarter, K., Strowig, T., Bang, H., Rech, J., Schett, G., et al. (2020) · Nutrients · doi:10.3390/nu12103207 · Cited by 94
“This is of relevance, as it was shown that SCFAs affected the immune system during inflammatory diseases by modifying gene expression profiles [18,19], cell chemotaxis [20,21], differentiation [6,22,23], proliferation [24–26] and apoptosis [27,28].”
BackgroundRole of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases
Rasouli‐Saravani, A., Jahankhani, K., Moradi, S., Gorgani, M., Shafaghat, Z., Mirsanei, Z., Mehmandar‐Oskuie, A., & Mirzaei, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114620 · Cited by 106
Kim, S.-H., Cho, B.-H., Kiyono, H., & Jang, Y.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02729-6 · Cited by 91
Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease
Moshkelgosha, S., Verhasselt, H. L., Masetti, G., Covelli, D., Biscarini, F., Horstmann, M., Daser, A., Westendorf, A. M., Jesenek, C., Philipp, S., et al. (2021) · Microbiome · doi:10.1186/s40168-020-00952-4 · Cited by 100
Shimizu, J., Kubota, T., Takada, E., Takai, K., Fujiwara, N., Arimitsu, N. N., Murayama, M. A., Ueda, Y., Wakisaka, S., Tomoko, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203657 · Cited by 99
Diet and Nutrients in Gastrointestinal Chronic Diseases
Corsello, A., Pugliese, D., Gasbarrini, A., & Armuzzi, A. (2020) · Nutrients · doi:10.3390/nu12092693 · Cited by 102
“An important product of fiber fermentation are SCFAs, which play multifactorial roles in energy regulation, host immunity and gut motility and absorption [43,44].”
BackgroundThe Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective
Wang, L., Cao, Z.-M., Zhang, L., Li, J.-M., & Lv, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923599 · Cited by 106
“Propionate and butyrate can inhibit the expression of CD40 in bone marrow dendritic cells (BMDCS), reduce the production of IL-6 and IL12P40, and thus inhibit the activation of BMDC (29).”
BackgroundImmunomodulatory Properties of Probiotics and Their Derived Bioactive Compounds
Thoda, C., & Touraki, M. (2023) · Applied Sciences · doi:10.3390/app13084726 · Cited by 96
“Both butyrate and propionate were found to exert immunomodulatory properties via modulation of gene expression in DCs [154].”
BackgroundBioactive Lipids and Their Derivatives in Biomedical Applications
Park, J.-W., Choi, J., Kim, D., Lee, S., Lee, B., Lee, Y., Kim, S., Kwon, S., Noh, M., Lee, M., et al. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.107 · Cited by 92
“Short-chain fatty acids Propionic acid Immunomodulatory effect on mature dendritic cells Anti-inflammatory activity Nastasi et al., 2015 Enhance regulatory T cell metabolism and function Multiple sclerosis Duscha et al., 2020 Alteration of bone marrow hematopoiesis Allergic airway disease Trompette…”
BackgroundMajumdar, A., Venkatesh, I. P. S., & Basu, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00803 · Cited by 92
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention
Thulasinathan, B., Suvilesh, K. N., Maram, S., Grossmann, E. M., Ghouri, Y. A., Teixeiro, E., Chan, J., Kaifi, J. T., & Rachagani, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2483780 · Cited by 93
“228 Importantly, a study has showed a positive correlation between LY6C hi monocyte levels in the brain and neurogenesis, 228 suggesting a potential role for SCFAs in this relationship, 229,230 which warrants further research.”
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
Uribe‐Herranz, M., Klein-González, N., Rodríguez‐Lobato, L. G., Juan, M., & de Larrea, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031026 · Cited by 88
“fragilis can promote the increase in systemic T helper cell type 1 (Th1) CD4+ T cells [39]; and SCFAs can regulate extrathymic/peripheral T regs [32] and DC cytokine production and function [34,35] (Figure 1).”
BackgroundLipid metabolism in dendritic cell biology
You, Z., & Chi, H. (2023) · Immunological Reviews · doi:10.1111/imr.13215 · Cited by 88
Warman, D. J., Jia, H., & Kato, H. (2022) · Nutrients · doi:10.3390/nu14040747 · Cited by 87
“also reported the anti-inflammatory properties of butyrate [23,73].”
BackgroundResultThe Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
Braumüller, H., Mauerer, B., Andris, J., Berlin, C., Wieder, T., & Kesselring, R. (2022) · Cells · doi:10.3390/cells12010138 · Cited by 90
“SCFAs prevent tumorigenesis by inhibiting LPS-induced expression of pro-inflammatory cytokines and induce colon adenoma and carcinoma cell apoptosis [183].”
BackgroundA double‐edged sword: Role of butyrate in the oral cavity and the gut
Guan, X., Li, W., & Meng, H. (2020) · Molecular Oral Microbiology · doi:10.1111/omi.12322 · Cited by 84
Fan, Y., Ju, T., Bhardwaj, T., Korver, D. R., & Willing, B. P. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03616-22 · Cited by 80
Gomes, S., Rodrigues, A., Pazienza, V., & Preto, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065069 · Cited by 83
“Comparing the three metabolites, acetate only exerts negligible effects, while both butyrate and propionate are described as being able to strongly modulate gene expression in both immature and mature human monocyte-derived dendritic cells [52].”
BackgroundCockburn, D. W., Suh, C. E., Medina, K. M. P., Duvall, R., Wawrzak, Z., Henrissat, B., & Koropatkin, N. M. (2017) · Molecular Microbiology · doi:10.1111/mmi.13881 · Cited by 81
“Butyrate also downregulates the expression of pro-inflammatory cytokines, leading to lower levels of inflammation in the gut (Nastasi et al., 2015).”
BackgroundShort-chain Fatty Acids: A Link Between Prebiotics And Microbiota In Chronic Kidney Disease
Esgalhado, M., Kemp, J. A., Damasceno, N. R., Fouque, D., & Mafra, D. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0059 · Cited by 68
Butyrate Improves Skin/Lung Fibrosis and Intestinal Dysbiosis in Bleomycin-Induced Mouse Models
Park, H. J., Jeong, O.-Y., Chun, S. H., Cheon, Y., Kim, M., Kim, S., & Lee, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052765 · Cited by 77
“Butyrate downregulates the release of proinflammatory cytokines from macrophages and dendritic cells (DCs) [19,20].”
Background
Metadata
- Authors
- Nastasi, C., Candela, M., Bonefeld, C. M., Geisler, C., Hansen, M., Krejsgaard, T., Biagi, E., Andersen, M. H., Brigidi, P., Ødum, N., Litman, T., & Woetmann, A.
- Affiliations
- University of Copenhagen (DK)
- University of Bologna (IT)
- Herlev Hospital (DK)
- Leo Pharma (Denmark) (DK)
- Corresponding author
- Woetmann, Anders
- ORCID
- Venue
- Scientific Reports
- Published
- 2015-11-06
- Volume
- 5
- Issue
- 1
- Pages
- 16148-16148
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4635422
- OpenAlex
- W2193435259
- Cited by
- 414
- References
- 45
- Citations by year
- 2026: 27 · 2025: 55 · 2024: 48 · 2023: 53 · 2022: 42 · 2021: 50 · 2020: 42 · 2019: 32 · 2018: 20 · 2017: 30 · 2016: 15
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Funders
- Kræftens Bekæmpelse
- Lundbeckfonden
- Novo Nordisk Fonden (NNF12OC0002036)
- H. Lundbeck A/S
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, butyrate, propionate, acetate, monocyte-derived dendritic cells, gut microbiota, host-microbiome interactions, chemokine expression, leukocyte migration, anti-inflammatory activity, interleukin-6, IL-12p40, transcriptional response
- MeSH terms
- Gastrointestinal Microbiome, Butyrates, Cells, Cultured, Dendritic Cells, Fatty Acids, Volatile, Humans, Inflammation, Leukocytes, Lipopolysaccharides, Monocytes, Propionates, Transcription, Genetic, Interleukin-6, Gene Expression, Chemokines, CXC, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.